B Oberg|P Bjerring - JoVE Visualize

Showing results (281-290 of 291) with videos related to

Pageof 30

Sort By:

Biochemical Pharmacology|January 1, 1989

An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogsH Bazin, J Chattopadhyaya, R Datema, et al.

Scandinavian Journal of Infectious Diseases|January 1, 1985

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipientsG Klintmalm, B Lönnqvist, B Oberg, et al.

Journal of Clinical Microbiology|May 29, 2001

Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infectionG Van den Bosch, G Locatelli, L Geerts, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitorsK Uberla, C Stahl-Hennig, D Böttiger, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitorsJ Balzarini, A Karlsson, A M Vandamme, et al.

Antimicrobial Agents and Chemotherapy|June 1, 1977

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphateB Eriksson, E Helgstrand, N G Johansson, et al.

Aging & Mental Health|January 30, 2003

The COPE index--a first stage assessment of negative impact, positive value and quality of support of caregiving in informal carers of older peopleK J McKee, I Philp, G Lamura, et al.

Virology|January 1, 1993

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptaseJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.

Science (New York, N.Y.)|September 1, 1978

Trisodium phosphonoformate, a new antiviral compoundE Helgstrand, B Eriksson, N G Johansson, et al.

Journal of Medicinal Chemistry|October 9, 1999

Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analoguesM Högberg, C Sahlberg, P Engelhardt, et al.

Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:

Pageof 30

Biochemical Pharmacology|January 1, 1989

An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogsH Bazin, J Chattopadhyaya, R Datema, et al.

Scandinavian Journal of Infectious Diseases|January 1, 1985

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipientsG Klintmalm, B Lönnqvist, B Oberg, et al.

Journal of Clinical Microbiology|May 29, 2001

Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infectionG Van den Bosch, G Locatelli, L Geerts, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitorsK Uberla, C Stahl-Hennig, D Böttiger, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitorsJ Balzarini, A Karlsson, A M Vandamme, et al.

Antimicrobial Agents and Chemotherapy|June 1, 1977

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphateB Eriksson, E Helgstrand, N G Johansson, et al.

Aging & Mental Health|January 30, 2003

The COPE index--a first stage assessment of negative impact, positive value and quality of support of caregiving in informal carers of older peopleK J McKee, I Philp, G Lamura, et al.

Virology|January 1, 1993

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptaseJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.

Science (New York, N.Y.)|September 1, 1978

Trisodium phosphonoformate, a new antiviral compoundE Helgstrand, B Eriksson, N G Johansson, et al.

Journal of Medicinal Chemistry|October 9, 1999

Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analoguesM Högberg, C Sahlberg, P Engelhardt, et al.

Pageof 30